000 | 01734 a2200529 4500 | ||
---|---|---|---|
005 | 20250516040554.0 | ||
264 | 0 | _c20110907 | |
008 | 201109s 0 0 eng d | ||
022 | _a1365-2249 | ||
024 | 7 |
_a10.1111/j.1365-2249.2011.04422.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTuinman, P R | |
245 | 0 | 0 |
_aLack of evidence of CD40 ligand involvement in transfusion-related acute lung injury. _h[electronic resource] |
260 |
_bClinical and experimental immunology _cAug 2011 |
||
300 |
_a278-84 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAcute Lung Injury _xdrug therapy |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
650 | 0 | 4 | _aBronchoalveolar Lavage Fluid |
650 | 0 | 4 |
_aCD40 Antigens _ximmunology |
650 | 0 | 4 |
_aCD40 Ligand _xblood |
650 | 0 | 4 |
_aChemokine CXCL2 _xblood |
650 | 0 | 4 |
_aChemokines _xblood |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenes, MHC Class I |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPlatelet Activation _ximmunology |
650 | 0 | 4 |
_aThiazolidinediones _xpharmacology |
650 | 0 | 4 | _aTransfusion Reaction |
700 | 1 | _aGerards, M C | |
700 | 1 | _aJongsma, G | |
700 | 1 | _aVlaar, A P | |
700 | 1 | _aBoon, L | |
700 | 1 | _aJuffermans, N P | |
773 | 0 |
_tClinical and experimental immunology _gvol. 165 _gno. 2 _gp. 278-84 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2249.2011.04422.x _zAvailable from publisher's website |
999 |
_c20866720 _d20866720 |